- Previous Close
25,400.00 - Open
25,400.00 - Bid 25,350.00 x --
- Ask 25,400.00 x --
- Day's Range
25,200.00 - 25,550.00 - 52 Week Range
23,750.00 - 29,350.00 - Volume
5,478 - Avg. Volume
6,750 - Market Cap (intraday)
149.646B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 900.00 (3.54%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
40,000.00
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
www.daihan.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 023910.KQ
View MorePerformance Overview: 023910.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 023910.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 023910.KQ
View MoreValuation Measures
Market Cap
149.65B
Enterprise Value
72.44B
Trailing P/E
4.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.73
Price/Book (mrq)
0.54
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
1.46
Financial Highlights
Profitability and Income Statement
Profit Margin
16.53%
Return on Assets (ttm)
7.69%
Return on Equity (ttm)
12.89%
Revenue (ttm)
204.19B
Net Income Avi to Common (ttm)
33.76B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
77.24B
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
12.01B